The Hydroxyzine Pamoate Capsules, cataloged under National Stock Number 6505-00-765-0823, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Pfizer Inc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 9 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-765-0823 |
| Primary Part Number | 4361 |
| Item Name | Hydroxyzine Pamoate Capsules |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Pfizer Inc |
| Status | CANCELLED |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Capsule Primary Container Content Quantity | 500.000 |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| 4361 PRIMARY | Pfizer Inc (USA) |
| 3946 | Armco Medical Supply Inc Dba Us Trading (USA) |
| NDC00069-5410-73 PRIMARY | Pfizer Inc (USA) |
| 01-4842 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00725-0100-05 PRIMARY | Circa Pharmaceutical Co Inc (USA) |
| NDC49884-0069-05 | Armco Medical Supply Inc Dba Us Trading (USA) |
| VISTARIL CAPSULES | Pfizer Inc (USA) |
| NDC51285-0265-04 PRIMARY | U S Dept of Veterans Affairs (USA) |
| NDC00182-1098-05 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
NSN 6505-00-765-0823 is a Hydroxyzine Pamoate Capsules, manufactured by Pfizer Inc, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-00-765-0823 has 9 cross-referenced part numbers: 4361 (Pfizer Inc), 3946 (Armco Medical Supply Inc Dba Us Trading), NDC00069-5410-73 (Pfizer Inc), 01-4842 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00725-0100-05 (Circa Pharmaceutical Co Inc) and 4 more.
There are 12 known substitutes for 6505-00-765-0823: 5315-00-010-3387, 2520-00-039-5831, 5970-00-157-0730 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for 4361: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Capsule Primary Container Content Quantity: 500.000; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT. 4 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-00-765-0823 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.